Kyoichi Kaira

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 68

Top Venues

Thoracic cancer

Medicina (Kaunas, Lithuania)

Japanese journal of clinical oncology

International journal of molecular sciences

Gunma University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Gunma University

Japan

PHD :: Oncology Clinical Development

Publications

Naoyuki Nogami, Toshio Kubo, Akihiro Bessho, Makoto Sakugawa, Satoshi Ikeo, Toshihide Yokoyama, Nobuhiko Seki, Ryosuke Ochiai, Nobukazu Fujimoto, Shuji Murakami, Kyoichi Kaira, Toshiyuki Harada, Daizo Kishino, Yuichi Takiguchi, Tsuneo Shimokawa, Katsuyuki Kiura, Natsumi Yamashita, Hiroaki Okamoto
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL). Japanese journal of clinical oncology 54 (7) (2024)
Naoyuki Nogami, Toshio Kubo, Akihiro Bessho, Makoto Sakugawa, Satoshi Ikeo, Toshihide Yokoyama, Nobuhiko Seki, Ryosuke Ochiai, Nobukazu Fujimoto, Shuji Murakami, Kyoichi Kaira, Toshiyuki Harada, Daizo Kishino, Yuichi Takiguchi, Tsuneo Shimokawa, Katsuyuki Kiura, Natsumi Yamashita, Hiroaki Okamoto
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL). Japanese journal of clinical oncology (2024)
Kyoichi Kaira, Yoshinobu Ichiki, Hisao Imai, Tomonori Kawasaki, Kosuke Hashimoto, Ichiei Kuji, Hiroshi Kagamu
Potential predictors of the pathologic response after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a narrative review. Translational lung cancer research 13 (5) (2024)
Kyoichi Kaira, Hisao Imai, Hiroshi Kagamu
Overcoming acquired resistance following osimertinib administration in EGFR-mutant lung adenocarcinoma. Translational lung cancer research 13 (5) (2024)
Kyoichi Kaira, Hisao Imai, Hiroshi Kagamu
Overcoming acquired resistance following osimertinib administration in EGFR-mutant lung adenocarcinoma. Translational lung cancer research 13 (5) (2024)
Naoyuki Nogami, Toshio Kubo, Akihiro Bessho, Makoto Sakugawa, Satoshi Ikeo, Toshihide Yokoyama, Nobuhiko Seki, Ryosuke Ochiai, Nobukazu Fujimoto, Shuji Murakami, Kyoichi Kaira, Toshiyuki Harada, Daizo Kishino, Yuichi Takiguchi, Tsuneo Shimokawa, Katsuyuki Kiura, Natsumi Yamashita, Hiroaki Okamoto
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL). Japanese journal of clinical oncology 54 (7) (2024)
Kyoichi Kaira, Yoshinobu Ichiki, Hisao Imai, Tomonori Kawasaki, Kosuke Hashimoto, Ichiei Kuji, Hiroshi Kagamu
Potential predictors of the pathologic response after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a narrative review. Translational lung cancer research 13 (5) (2024)
Naoyuki Nogami, Toshio Kubo, Akihiro Bessho, Makoto Sakugawa, Satoshi Ikeo, Toshihide Yokoyama, Nobuhiko Seki, Ryosuke Ochiai, Nobukazu Fujimoto, Shuji Murakami, Kyoichi Kaira, Toshiyuki Harada, Daizo Kishino, Yuichi Takiguchi, Tsuneo Shimokawa, Katsuyuki Kiura, Natsumi Yamashita, Hiroaki Okamoto
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL). Japanese journal of clinical oncology 54 (7) (2024)
Akitoshi Yanagihara, Satoshi Yamasaki, Kosuke Hashimoto, Ryo Taguchi, Tetsuya Umesaki, Hisao Imai, Kyoichi Kaira, Hiroyuki Nitanda, Hirozo Sakaguchi, Hironori Ishida, Kunihiko Kobayashi, Katsuhisa Horimoto, Hiroshi Kagamu
A Th1-like CD4 + T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer. Cancer research communications 3 (7) (2023)
Yuta Shibasaki, Takehiko Yokobori, Makoto Sohda, Ikuma Shioi, Naoya Ozawa, Chika Komine, Kunihiko Suga, Nobuhiro Nakazawa, Katsuya Osone, Takeshi Sasaki, Takuhisa Okada, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Kyoichi Kaira, Ken Shirabe, Hiroshi Saeki
Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy. International journal of molecular sciences 24 (3) (2023)
Kyoichi Kaira, Hisao Imai, Atsuto Mouri, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Kunihiko Kobayashi, Tomonori Kawasaki, Masanori Yasuda, Hiroshi Kagamu
Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinib. Thoracic cancer (2023)
Teruhiko Kamiya, Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Mitsuru Sandoh, Satoshi Takei, Kazuya Arai, Hiromi Nishiba, Junnosuke Mogi, Shiro Koizuka, Taeko Saito, Kyoko Obayashi, Kyoichi Kaira, Koichi Minato
A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer. Medicina (Kaunas, Lithuania) 59 (3) (2023)
Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Tomonori Kawasaki, Kunihiko Kobayashi, Hisao Imai, Hiroshi Kagamu
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer. International journal of clinical oncology 29 (2) (2023)
Yuta Shibasaki, Takehiko Yokobori, Makoto Sohda, Ikuma Shioi, Naoya Ozawa, Chika Komine, Kunihiko Suga, Nobuhiro Nakazawa, Katsuya Osone, Takeshi Sasaki, Takuhisa Okada, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Kyoichi Kaira, Ken Shirabe, Hiroshi Saeki
Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy. International journal of molecular sciences 24 (3) (2023)
Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Tomonori Kawasaki, Kunihiko Kobayashi, Hisao Imai, Hiroshi Kagamu
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer. International journal of clinical oncology 29 (2) (2023)
Teruhiko Kamiya, Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Mitsuru Sandoh, Satoshi Takei, Kazuya Arai, Hiromi Nishiba, Junnosuke Mogi, Shiro Koizuka, Taeko Saito, Kyoko Obayashi, Kyoichi Kaira, Koichi Minato
A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer. Medicina (Kaunas, Lithuania) 59 (3) (2023)
Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Tomonori Kawasaki, Kunihiko Kobayashi, Hisao Imai, Hiroshi Kagamu
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer. International journal of clinical oncology (2023)
Noriaki Sunaga, Kyoichi Kaira, Kimihiro Shimizu, Ichidai Tanaka, Yosuke Miura, Seshiru Nakazawa, Yoichi Ohtaki, Reika Kawabata-Iwakawa, Mitsuo Sato, Luc Girard, John D Minna, Takeshi Hisada
The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancer. Thoracic cancer (2023)
Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Yoshiaki Nagai, Takayuki Kishikawa, Ken Masubuchi, Takashi Osaki, Yosuke Miura, Yukihiro Umeda, Akihiro Ono, Hiroyuki Minemura, Yutaka Yamada, Junichi Nakagawa, Yuki Kozu, Hirokazu Taniguchi, Hiromitsu Ohta, Takashi Kasai, Kyoichi Kaira, Hiroshi Kagamu
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed. Thoracic cancer (2023)
Kyoichi Kaira, Ou Yamaguchi, Ichiro Naruse, Yukihiro Umeda, Takeshi Honda, Satoshi Watanabe, Kosuke Ichikawa, Shin Yanagisawa, Norimitsu Kasahara, Tetsuya Higuchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Atsuto Mouri, Hisao Imai, Kunihiko Iizuka, Tamotsu Ishizuka, Koichi Minato, Satoshi Suda, Hiroshi Kagamu, Keita Mori, Nobuhiko Seki, Ichiei Kuji
Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer. Cancer imaging : the official publication of the International Cancer Imaging Society 23 (1) (2023)
Kyoichi Kaira, Ou Yamaguchi, Ichiro Naruse, Yukihiro Umeda, Takeshi Honda, Satoshi Watanabe, Kosuke Ichikawa, Shin Yanagisawa, Norimitsu Kasahara, Tetsuya Higuchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Atsuto Mouri, Hisao Imai, Kunihiko Iizuka, Tamotsu Ishizuka, Koichi Minato, Satoshi Suda, Hiroshi Kagamu, Keita Mori, Nobuhiko Seki, Ichiei Kuji
Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer. Cancer imaging : the official publication of the International Cancer Imaging Society 23 (1) (2023)
Ou Yamaguchi, Keita Mori, Saori Takata, Kazuhiko Shibata, Kenichi Chikamori, Nozomu Kimura, Yoshiaki Nagai, Taku Nakagawa, Satoshi Igawa, Taishi Harada, Hiroshige Yoshioka, Hisashi Tanaka, Hitomi Nogawa, Toshihiro Shiozawa, Toshihiro Shiozawa, Kosuke Tsuji, Kunihiko Kobayashi, Kyoichi Kaira
Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study). Thoracic cancer (2023)
Teruhiko Kamiya, Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Mitsuru Sandoh, Satoshi Takei, Kazuya Arai, Hiromi Nishiba, Junnosuke Mogi, Shiro Koizuka, Taeko Saito, Kyoko Obayashi, Kyoichi Kaira, Koichi Minato
A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer. Medicina (Kaunas, Lithuania) 59 (3) (2023)
Yuta Shibasaki, Takehiko Yokobori, Makoto Sohda, Ikuma Shioi, Naoya Ozawa, Chika Komine, Kunihiko Suga, Nobuhiro Nakazawa, Katsuya Osone, Takeshi Sasaki, Takuhisa Okada, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Kyoichi Kaira, Ken Shirabe, Hiroshi Saeki
Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy. International journal of molecular sciences 24 (3) (2023)
Yuta Shibasaki, Takehiko Yokobori, Makoto Sohda, Ikuma Shioi, Naoya Ozawa, Chika Komine, Kunihiko Suga, Nobuhiro Nakazawa, Katsuya Osone, Takeshi Sasaki, Takuhisa Okada, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Kyoichi Kaira, Ken Shirabe, Hiroshi Saeki
Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy. International journal of molecular sciences 24 (3) (2023)
Noboru Oriuchi, Hideki Endoh, Kyoichi Kaira
Monitoring of Current Cancer Therapy by Positron Emission Tomography and Possible Role of Radiomics Assessment. International journal of molecular sciences 23 (16) (2022)
Hisao Imai, Erika Naito, Ou Yamaguchi, Kosuke Hashimoto, Hidetoshi Iemura, Yu Miura, Ayako Shiono, Atsuto Mouri, Kyoichi Kaira, Kunihiko Kobayashi, Hiroshi Kagamu
Pretreatment body mass index predicts survival among patients administered nivolumab monotherapy for pretreated non-small cell lung cancer. Thoracic cancer 13 (10) (2022)
Hisao Imai, Kyoichi Kaira, Hiroshi Kagamu
Advanced Research on Immune Checkpoint Inhibitor Therapy. Journal of clinical medicine 11 (18) (2022)
Ken Masubuchi, Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Hiroyuki Minemura, Yoshiaki Nagai, Yutaka Yamada, Takayuki Kishikawa, Yukihiro Umeda, Ayako Shiono, Hiroki Takechi, Jun Shiihara, Kyoichi Kaira, Kenya Kanazawa, Hirokazu Taniguchi, Takayuki Kaburagi, Hiroshi Kagamu, Koichi Minato
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival. Thoracic cancer 13 (19) (2022)
Ayako Shiono, Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Yoshiaki Nagai, Hiroyuki Minemura, Yutaka Yamada, Takayuki Kishikawa, Yukihiro Umeda, Hiroki Takechi, Ou Yamaguchi, Atsuto Mouri, Kyoichi Kaira, Hirokazu Taniguchi, Koichi Minato, Hiroshi Kagamu
Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancer. Cancer medicine (2022)
Yoshimasa Hachisu, Yasuhiko Koga, Shu Kasama, Kyoichi Kaira, Shogo Uno, Masakiyo Yatomi, Haruka Aoki-Saito, Hiroaki Tsurumaki, Asuka Jingu, Noriaki Sunaga, Toshitaka Maeno, Takeshi Hisada
The Relationship between Tumor Development and Sarcoidosis in Aspects of Carcinogenesis before and after the Onset of Sarcoidosis. Medicina (Kaunas, Lithuania) 58 (6) (2022)
Hiroshi Kagamu, Satoshi Yamasaki, Shigehisa Kitano, Ou Yamaguchi, Atsuto Mouri, Ayako Shiono, Fuyumi Nishihara, Yu Miura, Kosuke Hashimoto, Hisao Imai, Kyoichi Kaira, Kunihiko Kobayashi, Yae Kanai, Tatsuhiro Shibata, Katsuhisa Horimoto
Single-cell analysis reveals a CD4+ T cell cluster that correlates with PD-1 blockade efficacy. Cancer research (2022)
Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Teruhiko Kamiya, Mitsuru Sandoh, Satoshi Takei, Kazuya Arai, Hiromi Nishiba, Junnosuke Mogi, Kyoichi Kaira, Koichi Minato
A retrospective study of the efficacy and safety of naldemedine for opioid-induced constipation in thoracic cancer patients. Thoracic cancer 13 (16) (2022)
Takanori Abe, Misaki Iino, Satoshi Saito, Tomomi Aoshika, Yasuhiro Ryuno, Tomohiro Ohta, Mitsunobu Igari, Ryuta Hirai, Yu Kumazaki, Yu Miura, Kyoichi Kaira, Hiroshi Kagamu, Shinei Noda, Shingo Kato
Simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer treated with intensity modulated radiotherapy. Thoracic cancer 13 (20) (2022)
Takanori Abe, Yasuhiro Ryuno, Misaki Iino, Satoshi Saito, Tomomi Aoshika, Tomohiro Ohta, Mitsunobu Igari, Ryuta Hirai, Yu Kumazaki, Kyoichi Kaira, Hiroshi Kagamu, Hironori Ishida, Shin-Ei Noda, Shingo Kato
A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer. Japanese journal of clinical oncology 51 (12) (2021)
Kyoichi Kaira, Kunihiko Kobayashi, Ayako Shiono, Ou Yamaguchi, Kosuke Hashimoto, Atsuto Mouri, Shun Shinomiya, Yu Miura, Hisao Imai, Hiroshi Kagamu
Effectiveness of EGFR-TKI rechallenge immediately after PD-1 blockade failure. Thoracic cancer 12 (6) (2021)
Hisao Imai, Ou Yamaguchi, Keita Mori, Kosuke Hashimoto, Tomoe Akagami, Shun Shinomiya, Yu Miura, Ayako Shiono, Atsuto Mouri, Kyoichi Kaira, Kunihiko Kobayashi, Hiroshi Kagamu
Clinical impact of post-progression survival on overall survival in patients receiving nivolumab monotherapy as a second-line treatment for advanced non-small cell lung cancer. Thoracic cancer 12 (8) (2021)
Hisao Imai, Ryoichi Onozato, Kyoichi Kaira, Sayaka Kawashima, Ken Masubuchi, Toshiteru Nagashima, Kohei Tajima, Koichi Minato
Course of postoperative relapse in non-small cell lung cancer is strongly associated with post-progression survival. Thoracic cancer 12 (20) (2021)
Kyoichi Kaira, Hisao Imai, Atsuto Mouri, Ou Yamaguchi, Hiroshi Kagamu
Clinical Effectiveness of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with a Poor Performance Status. Medicina (Kaunas, Lithuania) 57 (11) (2021)
Hisao Imai, Ryoichi Onozato, Maiko Ginnan, Daijiro Kobayashi, Kyoichi Kaira, Koichi Minato
Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations. Medicina (Kaunas, Lithuania) 57 (5) (2021)
Yoichi Ohtaki, Kyoichi Kaira, Toshiki Yajima, Bilguun Erkhem-Ochir, Osamu Kawashima, Mitsuhiro Kamiyoshihara, Hitoshi Igai, Ryoichi Onozato, Takashi Ibe, Takayuki Kosaka, Seshiru Nakazawa, Toshiteru Nagashima, Tetsunari Oyama, Ken Shirabe
Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung. Thoracic cancer 12 (20) (2021)
Kyoichi Kaira, Hisao Imai, Ou Yamaguchi, Atsuto Mouri, Hiroshi Kagamu
Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma. Cancers 13 (21) (2021)
Hisao Imai, Takayuki Kishikawa, Hiroyuki Minemura, Yutaka Yamada, Tatsuya Ibe, Ou Yamaguchi, Atsuto Mouri, Yoichiro Hamamoto, Kenya Kanazawa, Takashi Kasai, Kyoichi Kaira, Takayuki Kaburagi, Koichi Minato, Kunihiko Kobayashi, Hiroshi Kagamu
Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer. Cancer medicine 10 (20) (2021)
Hisao Imai, Kyoichi Kaira, Ken Masubuchi, Koichi Minato
Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study. Current oncology (Toronto, Ont.) 29 (1) (2021)
Yutaka Yamada, Hisao Imai, Tomohide Sugiyama, Hiroyuki Minemura, Kenya Kanazawa, Takashi Kasai, Koichi Minato, Kyoichi Kaira, Takayuki Kaburagi
Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations. Medicina (Kaunas, Lithuania) 57 (9) (2021)
Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Kousuke Hashimoto, Yu Miura, Ayako Shiono, Shun Shinomiya, Hisao Imai, Kunihiko Kobayashi, Hiroshi Kagamu
Effect of Systemic Steroid Use for Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Receiving PD-1 Blockade Drugs. Journal of clinical medicine 10 (16) (2021)
Kyoichi Kaira, Hisao Imai, Hiroshi Kagamu
Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma. Cancers 13 (5) (2021)
Ayako Shiono, Takashi Fujino, Kyoichi Kaira, Tomomi Kato, Masanori Yasuda, Kunihiko Kobayashi, Hiroshi Kagamu
Primary thymic adenocarcinoma with an aggressive clinical course: An autopsy case showing signet ring cell-like features. Thoracic cancer 11 (12) (2020)
Ou Yamaguchi, Kyoichi Kaira, Shun Shinomiya, Atsuto Mouri, Kosuke Hashimoto, Ayako Shiono, Yu Miura, Tomoe Akagami, Hisao Imai, Kunihiko Kobayashi, Hiroshi Kagamu
Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumab. Thoracic cancer 12 (3) (2020)
Katsuhito Sasaki, Yasuhiro Nakamura, Natsuki Baba, Yukiko Teramoto, Yuri Asami, Kyoichi Kaira, Hiroshi Kagamu, Tomonori Kawasaki, Eiichi Arai, Akifumi Yamamoto
Verrucous skin lesion caused by neuropathy misdiagnosed as squamous cell carcinoma and treated with amputation surgery. The Journal of dermatology 47 (5) (2020)
Yu Miura, Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Ayako Shiono, Kosuke Hashimoto, Fuyumi Nishihara, Shun Shinomiya, Tomoe Akagami, Yoshitake Murayama, Takanori Abe, Shin-Ei Noda, Shingo Kato, Kunihiko Kobayashi, Hiroshi Kagamu
Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events. Thoracic cancer 11 (5) (2020)
Hisao Imai, Hiroyuki Minemura, Takayuki Kishikawa, Yutaka Yamada, Kensuke Suzuki, Yukihiro Umeda, Satoshi Wasamoto, Norimitsu Kasahara, Shinichi Ishihara, Ou Yamaguchi, Ichiro Naruse, Junji Uchino, Keita Mori, Kenya Kanazawa, Yoko Shibata, Takashi Kasai, Takayuki Kaburagi, Kyoichi Kaira, Koichi Minato
Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis. Thoracic cancer 11 (10) (2020)
Kosuke Hashimoto, Kyoichi Kaira, Ou Yamaguchi, Atsuto Mouri, Ayako Shiono, Yu Miura, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu, Ichiei Kuji
Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer. Journal of clinical medicine 9 (3) (2020)
Kengo Kuriyama, Tamami Higuchi, Takehiko Yokobori, Hideyuki Saito, Tomonori Yoshida, Keigo Hara, Shigemasa Suzuki, Makoto Sakai, Makoto Sohda, Tetsuya Higuchi, Yoshito Tsushima, Takayuki Asao, Kyoichi Kaira, Hiroyuki Kuwano, Ken Shirabe, Hiroshi Saeki
Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma. Cancer science 111 (6) (2020)
Reiko Sakurai, Kyoichi Kaira, Yosuke Miura, Noriaki Sunaga, Ryusei Saito, Tetsunari Oyama, Takeshi Hisada, Masanobu Yamada
Clinical significance of topoisomerase-II expression in patients with advanced non-small cell lung cancer treated with amrubicin. Thoracic cancer 11 (2) (2020)
Takanori Abe, Satoshi Saito, Misaki Iino, Tomomi Aoshika, Yasuhiro Ryuno, Tomohiro Ohta, Mitsunobu Igari, Ryuta Hirai, Yu Kumazaki, Yu Miura, Kyoichi Kaira, Hiroshi Kagamu, Shin-Ei Noda, Shingo Kato
Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer in comparison with chemoradiotherapy alone. Thoracic cancer 12 (2) (2020)
Rong Wang, Tadaaki Yamada, Kenji Kita, Hirokazu Taniguchi, Sachiko Arai, Koji Fukuda, Minoru Terashima, Akihiko Ishimura, Akihiro Nishiyama, Azusa Tanimoto, Shinji Takeuchi, Koshiro Ohtsubo, Kaname Yamashita, Tomoyoshi Yamano, Akihiro Yoshimura, Koichi Takayama, Kyoichi Kaira, Yoshihiko Taniguchi, Shinji Atagi, Hisanori Uehara, Rikinari Hanayama, Isao Matsumoto, Xujun Han, Kunio Matsumoto, Wei Wang, Takeshi Suzuki, Seiji Yano
Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer. Nature communications 11 (1) (2020)
Norimitsu Kasahara, Hisao Imai, Ichiro Naruse, Yusuke Tsukagoshi, Mie Kotake, Noriaki Sunaga, Kyoichi Kaira, Toshitaka Maeno, Takayuki Asao, Takeshi Hisada
Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment. Thoracic cancer 11 (8) (2020)
Kyoichi Kaira, Atsuto Mouri, Shingo Kato, Kenichi Yoshimura, Hiroshi Kagamu, Kunihiko Kobayashi
A phase II study of daily carboplatin plus irradiation followed by durvalumab for stage III non-small cell lung cancer patients with PS 2 up to 74 years old and patients with PS 0 or 1 from 75 years: NEJ039A (trial in progress). BMC cancer 20 (1) (2020)
Hiroyuki Minemura, Hiroshi Moriya, Hisao Imai, Tomohide Sugiyama, Yutaka Yamada, Mitsunori Higuchi, Kyoichi Kaira, Yuki Ozaki, Kenya Kanazawa, Hiroshi Yokouchi, Takashi Kasai, Takayuki Kaburagi, Hiroyuki Suzuki, Koichi Minato, Yoko Shibata
Prognostic value of morphological characteristics assessed by CT scan in patients with non-small cell lung cancer treated with nivolumab. Thoracic cancer 11 (12) (2020)
Ou Yamaguchi, Kyoichi Kaira, Tomonori Kawasaki, Atsuto Mouri, Kosuke Hashimoto, Ayako Shiono, Shun Shinomiya, Yu Miura, Fuyumi Nishihara, Yoshitake Murayama, Kunihiko Kobayashi, Satoshi Mochida, Hiroshi Kagamu
Severe hepatotoxicity due to osimertinib after nivolumab therapy in patients with non-small cell lung cancer harboring EGFR mutation. Thoracic cancer 11 (4) (2020)
Ayako Shiono, Kyoichi Kaira, Atsuto Mouri, Ou Yamaguchi, Kosuke Hashimoto, Takahiro Uchida, Yu Miura, Fuyumi Nishihara, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu
Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients. Thoracic cancer 10 (4) (2019)
Hisao Imai, Kyoichi Kaira, Keita Mori, Mie Kotake, Masumi Mitani, Naoko Kawashima, Takeshi Hisada, Koichi Minato
Post-progression survival is highly linked to overall survival in patients with non-small-cell lung cancer harboring sensitive EGFR mutations treated with first-line epidermal growth factor receptor-tyrosine kinase inhibitors. Thoracic cancer 10 (12) (2019)
Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, Atsuto Mouri, Yu Miura, Ayako Shiono, Fuyumi Nishihara, Yoshitake Murayama, Shin-Ei Noda, Shingo Kato, Kunihiko Kobayashi, Hiroshi Kagamu
Radiotherapy is an independent prognostic marker of favorable prognosis in non-small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab. Thoracic cancer 10 (4) (2019)
Atsuto Mouri, Kyoichi Kaira, Ayako Shiono, Ou Yamaguchi, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu
Clinical significance of primary prophylactic pegylated-granulocyte-colony stimulating factor after the administration of ramucirumab plus docetaxel in patients with previously treated non-small cell lung cancer. Thoracic cancer 10 (4) (2019)
Hisao Imai, Kimihiro Shimizu, Osamu Kawashima, Hideki Endoh, Kazuyoshi Imaizumi, Yasuhiro Goto, Mitsuhiro Kamiyoshihara, Masayuki Sugano, Ryohei Yamamoto, Shigebumi Tanaka, Atsushi Fujita, Yoshihito Kogure, Yukio Seki, Akira Mogi, Tetsunari Oyama, Koichi Minato, Takayuki Asao, Kyoichi Kaira
Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma. Cancers 11 (11) (2019)
Takahiro Uchida, Kyoichi Kaira, Ou Yamaguchi, Atsuto Mouri, Ayako Shiono, Yu Miura, Kosuke Hashimoto, Fuyumi Nishihara, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu
Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer. Thoracic cancer 10 (4) (2019)
Kosuke Hashimoto, Kyoichi Kaira, Kunihiko Kobayashi, Yoshitake Murayama, Hiroshi Kagamu
Spontaneous aspiration of a long tree twig as foreign body. Respirology case reports 7 (3) (2019)

Kyoichi Kaira.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kyoichi Kaira